Clinical Trials
9 trialsNCT04897321 2026-05-19
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
St. Jude Children's Research Hospital
Phase 1 Recruiting
NCT06239272 2026-05-19
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
St. Jude Children's Research Hospital
Phase 1/2 Recruiting
NCT05985161 2026-05-06
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT07298083 2026-04-09
DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins
M.D. Anderson Cancer Center
Recruiting
NCT03141021 2026-03-09
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Washington University School of Medicine
Recruiting
NCT04872543 2026-02-05
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT06515860 2026-01-09
NF1-TED
Boston Children's Hospital
Recruiting
NCT06849986 2026-01-08
TAIS
Fudan University
Phase 2 Recruiting